Oncology
Matthew Zibelman, M.D.
Medical Oncologist, Fox Chase Cancer Center
Philadelphia, PA
Dr. Matthew R. Zibelman is a medical oncologist specializing in genitourinary cancers, with primary focus on renal cell carcinoma and urothelial/bladder cancer. He treats patients across all phases of malignant disease, from initial diagnosis through advanced stages. His clinical expertise includes immunotherapy approaches for kidney and bladder cancers, and he actively participates in clinical trials offering patients access to emerging therapies. At Fox Chase Cancer Center, Dr. Zibelman works
19+
Years in Practice
Credentials
Board Certifications
- Internal Medicine (American Board of Internal Medicine)
- Medical Oncology (American Board of Internal Medicine)
Education & Training
- Lewis Katz School of Medicine at Temple University — M.D. (Class of 2007)
- University of Illinois College of Medicine at Chicago — Residency, Internal Medicine (2007-2011)
- Fox Chase Cancer Center — Fellowship, Hematology and Medical Oncology (2012-2015)
Peer Recognition
- Castle Connolly — Top Doctor
2023-2026 (4 years)
Clinical Focus
Subspecialties
Medical OncologyGenitourinary Oncology
Conditions & Treatments
Prostate CancerBladder CancerKidney CancerGenitourinary OncologyImmunotherapyCancer SurvivorshipAcute Lymphoblastic LeukemiaChemotherapyHematologic Malignancies
Practice Details
Hospital Affiliations
- Fox Chase Cancer Center
- Temple University Hospital
- Doylestown Hospital
- St. Luke's Hospital
Languages
English
Experience
19+ years in practice